Lynn Morris

1981–2025 年に発表

138
論文数
23,200
被引用数
86
h 指数
136
i10 指数

被引用数

Lynn Morris の年別被引用数1982 年: 被引用 4 件1983 年: 被引用 14 件1984 年: 被引用 13 件1985 年: 被引用 9 件1986 年: 被引用 6 件1987 年: 被引用 12 件1988 年: 被引用 9 件1989 年: 被引用 6 件1990 年: 被引用 6 件1991 年: 被引用 5 件1992 年: 被引用 12 件1993 年: 被引用 19 件1994 年: 被引用 23 件1995 年: 被引用 26 件1996 年: 被引用 17 件1997 年: 被引用 12 件1998 年: 被引用 20 件1999 年: 被引用 13 件2000 年: 被引用 22 件2001 年: 被引用 29 件2002 年: 被引用 27 件2003 年: 被引用 40 件2004 年: 被引用 40 件2005 年: 被引用 47 件2006 年: 被引用 76 件2007 年: 被引用 80 件2008 年: 被引用 83 件2009 年: 被引用 183 件2010 年: 被引用 170 件2011 年: 被引用 283 件2012 年: 被引用 280 件2013 年: 被引用 223 件2014 年: 被引用 217 件2015 年: 被引用 296 件2016 年: 被引用 289 件2017 年: 被引用 284 件2018 年: 被引用 209 件2019 年: 被引用 641 件2020 年: 被引用 571 件2021 年: 被引用 752 件2022 年: 被引用 407 件2023 年: 被引用 288 件2024 年: 被引用 503 件2025 年: 被引用 255 件2026 年: 被引用 2 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,562 件、この内訳の 37.7%イギリス: 引用元論文 555 件、この内訳の 8.2%南アフリカ: 引用元論文 529 件、この内訳の 7.8%オランダ: 引用元論文 237 件、この内訳の 3.5%フランス: 引用元論文 218 件、この内訳の 3.2%中国: 引用元論文 216 件、この内訳の 3.2%カナダ: 引用元論文 206 件、この内訳の 3%ドイツ: 引用元論文 192 件、この内訳の 2.8%スイス: 引用元論文 177 件、この内訳の 2.6%オーストラリア: 引用元論文 141 件、この内訳の 2.1%イタリア: 引用元論文 108 件、この内訳の 1.6%ベルギー: 引用元論文 101 件、この内訳の 1.5%
0%37.7%その他 22.8%

分野

  • Immunology and Microbiology44.5%
  • Medicine42.9%
  • Biochemistry, Genetics and Molecular Biology7.7%
  • Agricultural and Biological Sciences0.7%
  • Neuroscience0.7%
  • Social Sciences0.7%
  • その他2.8%

トピック

  • HIV Research and Treatment16.3%
  • HIV/AIDS Research and Interventions7.3%
  • HIV/AIDS drug development and treatment7.3%
  • Immune Cell Function and Interaction5.8%
  • Monoclonal and Polyclonal Antibodies Research5.5%
  • T-cell and B-cell Immunology3.7%
  • その他54.1%

共著者

全論文

検索で開く
  1. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simbarashe Takuva, Margarita M. Gomez Lorenzo, David Burns, Nicole Espy, April K. Randhawa, Nidhi Kochar, Estelle Piwowar‐Manning, Deborah Donnell, Nirupama Sista, P. Andrew, James G. Kublin, Glenda Gray, Julie E. Ledgerwood, John R. Mascola, Myron S. Cohen - New England Journal of Medicine 2021 被引用: 539

  2. High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity

    著者: , , , , , , , , , , , , , , , , , , , , - Cell 2019 被引用: 343

  3. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelvin Chiong, Georgia D. Tomaras, P. Andrew, Bryan T. Mayer, Daniel B. Reeves, Magdalena E. Sobieszczyk, Nigel Garrett, Jorge Sánchez, Cynthia L. Gay, Joseph Makhema, Carolyn Williamson, James I. Mullins, John Hural, Myron S. Cohen, Lawrence Corey, David C. Montefiori, Lynn Morris - Nature Medicine 2022 被引用: 126

  4. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yongping Yang, Zhenhai Zhang, NISC Comparative Sequencing, James C. Mullikin, James Μ. Binley, Rogier W. Sanders, Ian A. Wilson, John P. Moore, Andrew C. Ward, George Georgiou, Carolyn Williamson, Salim S. Abdool Karim, Lynn Morris, Peter D. Kwong, Lawrence Shapiro, John R. Mascola - Nature 2014 被引用: 756

  5. Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature, Nat. 2014 被引用: 779

  6. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynn Morris, John R. Mascola - Journal of Virology 2015 被引用: 261

  7. Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David C. Montefiori, Ashley M. Trama, Hua‐Xin Liao, Thomas B. Kepler, M. Anthony Moody, Feng Gao, Samuel J. Danishefsky, John R. Mascola, George M. Shaw, Beatrice H. Hahn, Stephen C. Harrison, Bette Korber, Barton F. Haynes - Science Translational Medicine 2017 被引用: 290

  8. Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Virology 2008 被引用: 624

  9. Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection

    著者: , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2016 被引用: 200

  10. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adrian B. McDermott, Mattia Bonsignori, Barton F. Haynes, Penny L. Moore, Lynn Morris, Kelly K. Lee, Lawrence Shapiro, John R. Mascola, Peter D. Kwong - Nature Structural & Molecular Biology 2015 被引用: 195

  11. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

    著者: , , , , , , , , , , , , , , , , , , , - Cell Reports 2020 被引用: 84

  12. Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Seaman, Lawrence Corey, Myron S. Cohen, John Hural, M. Juliana McElrath, James I. Mullins, David C. Montefiori, Penny L. Moore, Carolyn Williamson, Lynn Morris - PLoS Pathogens 2023 被引用: 56

  13. Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection

    著者: , , , , , , , , , , , , , , , - Cell Host & Microbe 2018 被引用: 129

  14. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter B. Gilbert, Lawrence Corey, Glenda Gray, M. Juliana McElrath - The Lancet HIV 2018 被引用: 124

  15. The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 + T Cell Decline and High Viral Load during Acute Infection

    著者: , , , , , , , , , , , , - Journal of Virology 2011 被引用: 472

  16. Neutralization tiers of HIV-1

    著者: , , , - Current Opinion in HIV and AIDS 2017 被引用: 105

  17. Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgia D. Tomaras, S. Munir Alam, Hua-Xin Liao, Barton F. Haynes - Journal of Virology 2011 被引用: 439

  18. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Avelin F. Aghokeng, Anders Sönnerborg, Ujjwal Neogi, W. Jeffrey Fessel, Simon Agolory, Chunfu Yang, José Luís Blanco, James Juma, Erasmus Smit, Daniel Schmidt, Christine Watera, Juliet Asio, Wilford Kurungi, Anna Tostevin, Tal El‐Hay, Nathan Clumeck, Dominique Goedhals, Cloete van Vuuren, Philip Armand Bester, Caroline Sabin, Irene Mukui, Maria Mercedes Santoro, Carlo Federico Perno, Gillian Hunt, Lynn Morris, Ricardo Camacho, Túlio de Oliveira, Deenan Pillay, Eugene Schulter, Akio Murakami-Ogasawara, Gustavo Reyes‐Terán, Karla Romero, Santiago Ávila‐Ríos, Sunee Sirivichayakul, Kiat Ruxrungtham, Suwanna Mekprasan, David Dunn, Pontiano Kaleebu, Elliot Raizes, Rami Kantor, Robert W. Shafer, Ravindra K. Gupta - The Lancet Infectious Diseases 2016 被引用: 275

  19. Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shi-Mao Xia, David C. Montefiori, Garnett Kelsoe, Feng Gao, John R. Mascola, M. Anthony Moody, Kevin O. Saunders, Hua-Xin Liao, Georgia D. Tomaras, George Georgiou, Barton F. Haynes - Science Immunology 2017 被引用: 159

  20. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

    著者: , , , , , , , , , , , - PLoS Pathogens 2019 被引用: 99

  21. Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Andrew, José A. Hidalgo, Jesse N. Clark, Fatima Laher, Catherine Orrell, Ian Frank, Pedro Gonzáles, Srilatha Edupuganti, Nyaradzo Mgodi, Lawrence Corey, Lynn Morris, David C. Montefiori, Myron S. Cohen, Peter B. Gilbert, Georgia D. Tomaras - EBioMedicine 2023 被引用: 33

  22. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

    著者: , , , , , , , , , , , , , , , , - Science 2010 被引用: 2,443

  23. Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2023 被引用: 40

  24. Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bupe Sichalwe, Mah Asombang, Christine Namakobo, Sam Mundia, Lumbwe Banda, Joyce Mapanza, Jacinta Shilimi, Emmanuel Kapesa, Abisai Kisinda, Cornelia Lueer, Lilian Njovu, Wiston William, Faith Mlagalila, Elizabeth Ntapara, Willhelmina Olomi, Nnhamo Chiwerengo, Revocatus Kunambi, Bahati Myombe, Rosemary Mwilinga, Neema Mbinda, Joyce Masala, Joseph Mapunda, On Ho, Denelle Reilly, Liz Briesemeister, Marianne Hansen, Jill Zeller, Simbarashe Takuva, Caroline Brackett, Jack Heptinstall, Kelly E. Seaton, David Beaumont, Lu Zhang, Sheetal Sawant, Marcella Sarzotti‐Kelsoe, Tandile Hermanus, Valerie Bekker, Stephen De Rosa, Saleha Omarjee, Stephany Wilcox, Shamiska Rohith, Asiphe Basethi, R Da Costa Noble, Daryl E. Morris - Clinical Infectious Diseases 2020 被引用: 35